In the past 6 years, GHC's interest in healthcare has only increased. To date, GHC has invested in more than 160 companies in the fields of biopharmaceuticals, medical devices, healthcare services, and pharmaceutical retailing, of which more than 100 are Chinese companies. The total investment amount is more than 120 billion RMB, and the total market value of invested companies is more than 2.5 trillion RMB. However, Gao Tiles has always kept a low profile and seldom disclosed its investment logic and layout in the medical field to the outside world.